Montuenga LM - Search Results

1

Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates.

Warren KE, Patel MC, McCully CM, Montuenga LM, Balis FM. Warren KE, et al. Among authors: montuenga lm. Cancer Chemother Pharmacol. 2000;45(3):207-12. doi: 10.1007/s002800050031. Cancer Chemother Pharmacol. 2000. PMID: 10663638 Free article.

2

Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin.

Gonzalez-Moreno O, Calvo A, Joshi BH, Abasolo I, Leland P, Wang Z, Montuenga L, Puri RK, Green JE. Gonzalez-Moreno O, et al. Int J Cancer. 2005 May 10;114(6):870-8. doi: 10.1002/ijc.20789. Int J Cancer. 2005. PMID: 15609296

3

Adrenomedullin functions as an important tumor survival factor in human carcinogenesis.

Cuttitta F, Pío R, Garayoa M, Zudaire E, Julián M, Elsasser TH, Montuenga LM, Martínez A. Cuttitta F, et al. Among authors: montuenga lm. Microsc Res Tech. 2002 Apr 15;57(2):110-9. doi: 10.1002/jemt.10059. Microsc Res Tech. 2002. PMID: 11921362 Free article. Review.

4

Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution.

Becerra SP, Fariss RN, Wu YQ, Montuenga LM, Wong P, Pfeffer BA. Becerra SP, et al. Among authors: montuenga lm. Exp Eye Res. 2004 Feb;78(2):223-34. doi: 10.1016/j.exer.2003.10.013. Exp Eye Res. 2004. PMID: 14729355

5

Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.

Ajona D, Castaño Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R. Ajona D, et al. Among authors: montuenga lm. Cancer Res. 2004 Sep 1;64(17):6310-8. doi: 10.1158/0008-5472.CAN-03-2328. Cancer Res. 2004. PMID: 15342420

6

Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma.

Calvo A, Abasolo I, Jiménez N, Wang Z, Montuenga L. Calvo A, et al. Microsc Res Tech. 2002 Apr 15;57(2):98-104. doi: 10.1002/jemt.10056. Microsc Res Tech. 2002. PMID: 11921360 Free article. Review.

7

Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo.

Abasolo I, Yang L, Haleem R, Xiao W, Pio R, Cuttitta F, Montuenga LM, Kozlowski JM, Calvo A, Wang Z. Abasolo I, et al. Among authors: montuenga lm. Mol Cell Endocrinol. 2003 Jan 31;199(1-2):179-87. doi: 10.1016/s0303-7207(02)00229-0. Mol Cell Endocrinol. 2003. PMID: 12581889

8

Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism.

Abasolo I, Wang Z, Montuenga LM, Calvo A. Abasolo I, et al. Among authors: montuenga lm. Biochem Biophys Res Commun. 2004 Sep 24;322(3):878-86. doi: 10.1016/j.bbrc.2004.08.006. Biochem Biophys Res Commun. 2004. PMID: 15336545 Free article.

9

Adrenomedullin prevents apoptosis in prostate cancer cells.

Abasolo I, Montuenga LM, Calvo A. Abasolo I, et al. Among authors: montuenga lm. Regul Pept. 2006 Jan 15;133(1-3):115-22. doi: 10.1016/j.regpep.2005.09.026. Epub 2005 Nov 17. Regul Pept. 2006. PMID: 16297990 Free article.

10

Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma.

Jiménez N, Abasolo I, Jongsma J, Calvo A, Garayoa M, van der Kwast TH, van Steenbrugge GJ, Montuenga LM. Jiménez N, et al. Among authors: montuenga lm. Mol Carcinog. 2003 Sep;38(1):14-24. doi: 10.1002/mc.10134. Mol Carcinog. 2003. PMID: 12949839 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters